Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis. (2019)

First Author: Al-Chalabi A

Attributed to: STRENGTH funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/fjc.0000000000000728

PubMed Identifier: 31730560

Publication URI: http://europepmc.org/abstract/MED/31730560

Type: Journal Article/Review

Volume: 74

Parent Publication: Journal of cardiovascular pharmacology

Issue: 5

ISSN: 0160-2446